Illumina and NVIDIA have announced a groundbreaking collaboration to advance multiomic data analysis, promising to accelerate drug discovery and precision health. By integrating Illumina’s sequencing technologies with NVIDIA’s AI tools, the partnership aims to revolutionize the analysis and interpretation of genomic data.